Physician profile
Michael Picozzo
NPI 1407221666
$526.56
in general payments reported to CMS, 2019-2025
9 companies · $174 in 2025
The $174 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $251 · 2022: $17.25 · 2023: $15.11 · 2024: $69.43 · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $258.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $203.23 | 2021-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $157.30 | 2021-2023 | Xarelto |
| Boston Scientific Corporation | $45.55 | 2021-2024 | Bodyguardian |
| Alnylam Pharmaceuticals INC. | $31.44 | 2024-2025 | Onpattro |
| Scpharmaceuticals INC. | $29.48 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.57 | 2024 | Jardiance |
| Actelion Pharmaceuticals US, INC. | $15.18 | 2025 | Uptravi, Opsumit |
| E.R. Squibb & Sons, L.L.C. | $13.90 | 2025 | Eliquis |
| Merck Sharp & Dohme LLC | $12.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Picozzo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.